NewGenIvf (NIVF) Return on Sales (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Return on Sales of 0.05% for Q4 2025, down 5.0% YoY from 0.06% in Q4 2024, and down 141.48% sequentially from 0.13% in Q3 2025.
NewGenIvf (NIVF) Return on Sales (2024 - 2025) Analysis & Trends
NewGenIvf has disclosed Return on Sales across 2 years of filings, most recently posting 0.05% for Q4 2025.
- In Q4 2025, Return on Sales fell 5.0% year-over-year to 0.05%; the TTM figure through Dec 2025 stood at 0.02% (changed N/A YoY), while the FY2025 annual figure was 0.02%, up 2.0% from the prior year.
- Return on Sales declined to 0.05% in Q4 2025, from 0.13% in the prior quarter.
- Over the last five years, Return on Sales for NIVF reached as high as 0.13% in Q3 2025 and fell as low as 0.05% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | 0.00% |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | 0.00% |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 0.00% |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 0.00% |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | 0.00% |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 0.00% |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 0.00% |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 0.00% |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | 0.06% |
| 10 | NewGenIvf | 25,304.95 | -1.41 Mn | 524,025.00 | -0.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.05% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |